JBAWX
Price
$31.92
Change
+$0.15 (+0.47%)
Updated
Oct 8 closing price
Net Assets
6.18B
RLBBX
Price
$38.77
Change
+$0.17 (+0.44%)
Updated
Oct 8 closing price
Net Assets
266.1B
Interact to see
Advertisement

JBAWX vs RLBBX

Header iconJBAWX vs RLBBX Comparison
Open Charts JBAWX vs RLBBXBanner chart's image
JHancock Balanced R6
Price$31.92
Change+$0.15 (+0.47%)
VolumeN/A
Net Assets6.18B
American Funds American Balanced R2
Price$38.77
Change+$0.17 (+0.44%)
VolumeN/A
Net Assets266.1B
JBAWX vs RLBBX Comparison Chart in %
View a ticker or compare two or three
VS
JBAWX vs. RLBBX commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JBAWX is a Buy and RLBBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBBX has more cash in the bank: 266B vs. JBAWX (6.18B). JBAWX pays higher dividends than RLBBX: JBAWX (1.88) vs RLBBX (1.11). JBAWX was incepted earlier than RLBBX: JBAWX (14 years) vs RLBBX (23 years). RLBBX (1.32) is less costly to investors than JBAWX (0.63). JBAWX is a more actively managed with annual turnover of: 67.00 vs. RLBBX (44.00). RLBBX has a lower initial minimum investment than JBAWX: RLBBX (250) vs JBAWX (1000000). JBAWX annual gain was more profitable for investors over the last year : 12.12 vs. RLBBX (9.08). JBAWX return over 5 years is better than : 47.78 vs. RLBBX (38.13).
JBAWXRLBBXJBAWX / RLBBX
Total Expense Ratio0.621.3247%
Annual Report Gross Expense Ratio0.631.3248%
Fund Existence14 years23 years-
Gain YTD12.73614.26289%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets6.18B266B2%
Annual Yield % from dividends1.881.11170%
Returns for 1 year12.129.08133%
Returns for 3 years54.7448.61113%
Returns for 5 years47.7838.13125%
Returns for 10 years101.4369.43146%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PACB1.510.11
+7.86%
Pacific Biosciences of California
PCOR74.443.03
+4.24%
Procore Technologies
VANI1.380.01
+0.73%
Vivani Medical
HAO1.29N/A
N/A
Haoxi Health Technology Limited
AVDX9.95N/A
N/A
AvidXchange Holdings